tiprankstipranks
Crescita Therpeutc J (TSE:CTX)
TSX:CTX
Canadian Market

Crescita Therpeutc (CTX) Stock Price & Analysis

12 Followers

CTX Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week RangeC$0.36 - C$0.73
Previous CloseC$0.44
Volume10.00K
Average Volume (3M)16.95K
Market Cap
C$8.80M
Enterprise ValueC$664.12K
Total Cash (Recent Filing)C$9.38M
Total Debt (Recent Filing)C$1.25M
Price to Earnings (P/E)-4.5
Beta0.45
May 08, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding19,988,899
10 Day Avg. Volume2,268
30 Day Avg. Volume16,952
Standard Deviation0.16
R-Squared0.22
Alpha-0.00790
Financial Highlights & Ratios
Price to Book (P/B)0.51
Price to Sales (P/S)1.78
Price to Cash Flow (P/CF)-8.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

23.09%0.00%0.00%76.91%
23.09% Insiders
0.00% Other Institutional Investors
76.91% Public Companies and
Individual Investors

CTX FAQ

What was Crescita Therpeutc J’s price range in the past 12 months?
Crescita Therpeutc J lowest stock price was C$0.36 and its highest was C$0.73 in the past 12 months.
    What is Crescita Therpeutc J’s market cap?
    Currently, no data Available
    When is Crescita Therpeutc J’s upcoming earnings report date?
    Crescita Therpeutc J’s upcoming earnings report date is May 08, 2024 which is in 3 days.
      How were Crescita Therpeutc J’s earnings last quarter?
      Crescita Therpeutc J released its earnings results on Mar 13, 2024. The company reported -C$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.008.
        Is Crescita Therpeutc J overvalued?
        According to Wall Street analysts Crescita Therpeutc J’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Crescita Therpeutc J pay dividends?
          Crescita Therpeutc J does not currently pay dividends.
          What is Crescita Therpeutc J’s EPS estimate?
          Crescita Therpeutc J’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Crescita Therpeutc J have?
          Crescita Therpeutc J has 19,988,900 shares outstanding.
            What happened to Crescita Therpeutc J’s price movement after its last earnings report?
            Crescita Therpeutc J reported an EPS of -C$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Crescita Therpeutc J?
              Currently, no hedge funds are holding shares in TSE:CTX
              ---

              Crescita Therpeutc Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -35.29%
              12-Months-Change

              Fundamentals

              Return on Equity
              -9.95%
              Trailing 12-Months
              Asset Growth
              -13.64%
              Trailing 12-Months

              Company Description

              Crescita Therpeutc J

              Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Resverlogix
              BriaCell Therapeutics
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis